S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

CGEM Cullinan Therapeutics Inc

12.02

-0.88 (-6.82%)

28 Dec 2024 - Closed

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Cullinan Therapeutics (NASDAQ:CGEM)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Cullinan Therapeutics Charts.

Cullinan Therapeutics (NASDAQ:CGEM)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Cullinan Therapeutics Charts.

Cullinan Therapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 21 December 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 21 December 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 21 December 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024
Friday 15 November 2024 (1 month ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Saturday 9 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Thursday 7 November 2024 (2 months ago) • GlobeNewswire Inc.

Cullinan Therapeutics to Participate in Fireside Chat at Stifel 2024 Healthcare Conference
Tuesday 5 November 2024 (2 months ago) • GlobeNewswire Inc.

More Cullinan Therapeutics Inc News Articles

Societe Generale Effekten

Boston Scientific Dl 01

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions